Launching the Alzheimer’s Disease Atlas at ADI2026 Conference
On 15 April, at the ADI Conference in Lyon, France, ADI shared the Alzheimer’s Disease Atlas, a first-of-its-kind website mapping the global landscape of Alzheimer’s disease.
News
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
Featured news
ADI CEO delivers speech at French Ministry of Health ahead of ADI2026 Conference
Read the transcript of ADI CEO Paola Barbarino's full speech at the French Ministry of Health, in Paris, France, 10 April 2026.
Values20 launches communiqué in preparation for G20
The communiqué calls on the G20 to lead the way in being truly values-driven for global impact and to operate in an environment where there is an agreement on shared values, clarity on unique values across nations, understanding of the values of difference and more.
Young onset dementia and post-diagnostic support
In this blog from Samantha Loi of the Australian Young Onset Dementia Special Interest Group (YOD-SIG), Samantha examines the complexities experienced by people living with young onset dementia when accessing post-diagnostic care, support and treatment.
TauRx reports top line results of their Phase 3 study LUCIDITY
Results from the LUCIDTY Phase 3 study suggests initial positive results for early and mild to moderate Alzheimer’s Disease
WISH launches new palliative care report with ADI
‘Integrating palliative care for older adults’ was written with ADI, The Worldwide Hospice Palliative Care Alliance (WHPCA), SANAD Hospice Lebanon and Hamad Medical Corporation (HMC).
Providing optimal dementia support to Indigenous people in North America
In this exercept from the essay 'Providing optimal dementia support to Indigenous people in North America', from the World Alzheimer Report 2022, Jordan P Lewis (Aleut) and Kristen M Jacklin write about the need for culturally tailored dementia care in Indigenous communities in North America.
Our sponsors’ committment to World Alzheimer’s Month
We asked some of our sponsors what inspires them to support World Alzheimer's Month as well as people living with dementia and their families.
Eisai reports positive results from their CLARITY AD Phase 3, lecanemab study
ADI warmly welcomes the positive initial data reported today by Eisai and Biogen on the CLARITY AD global Phase 3 clinical trial of lecanemab.
Up to 85% of people living with dementia may not receive post-diagnosis care – World Alzheimer Report reveals
In this press release, it is revealed that the World Alzheimer Report 2022 finds as many as 85 percent of people with dementia could be missing out on post-diagnosis care.